Insmed Inc at Evercore ISI Healthcare Conference Transcript
All right. Let's go ahead and get started. So thanks for joining us, everyone. Next up, we have Insmed's CFO, Sara Bonstein. Sara, over to you for an overview of the company, where things stand today on the back of a huge 2025 and another exciting '26.
After that, we'll get into it.
Questions & Answers
Great. Great. Thank you so much, Gavin, for having us, and thank you to Evercore for hosting this great conference. It's nice to be in some warm weather coming from an area where there was snow today. And so Insmed, as you said, we've had a tremendous 2025.
And what I think is most important for everyone to walk away from is we are not done yet. We believe we have the ability to have a tremendous '26 and beyond, pending additional data readouts. So let's maybe just dig into each one of those just really quickly, and then we'll go into your questions, of course.
ARIKAYCE specifically, this is our program that has
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
